Overview A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. Status: RECRUITING Trial end date: 2025-12-30 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate safety, tolerability, PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers.Phase: EARLY_PHASE1 Details Lead Sponsor: Shanghai Synvida Biotechnology Co.,Ltd.